The Centers for Medicare and Medicaid Services approved SPA 20-0011 on June 30, 2020. SPA 20-0011 waives cost sharing for all beneficiaries, regardless of the ultimate diagnosis, for testing services and treatments for COVID-19, including vaccines, specialized equipment, and therapies effective March 1, 2020. For more information read the approved SPA pages.